Clinical Trial transparency at Janssen
We believe transparency of clinical data advances science and medicine for patients
At Janssen, we see clinical trials as being at the heart of pharmaceutical research & development. We believe transparency of clinical trial data advances science and medicine. This is in the best interest of the patients who use our pharmaceutical products and the providers who prescribe them
Janssen is committed to the public sharing of clinical trial data through the overarching policy of its parent company Johnson & Johnson.
In the EMEA region our main initiatives in this area are: Involvement in Yale School of Medicine’s Open Data Access (YODA) Project to review every request for clinical data